Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 74,010

Document Document Title
WO/2017/205750A1
Provided herein are compositions and method for producing γ-polyglutamic acid (PGA). In particular, provided herein are bacterial co-culture systems and methods for producing PGA.  
WO/2017/203440A1
The present invention relates to a method for producing microbial probiotic biofilms and their uses in the biomedical, industrial, food and environmental field.  
WO/2017/201815A1
Provided are a high secretion heat resistant yeast genetically engineered fungus and use thereof. The yeast genetically engineered fungus is deposited in the China Center for Type Culture Collection (CCTCC), and is assigned with the acce...  
WO/2017/204374A1
The present invention provides a novel Lactobacillus species strain isolated from kimchi or human feces. The particular Bacillus species strain according to the present invention is highly safe by being isolated from kimchi or human fece...  
WO/2017/205645A1
Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are disclosed for providing beneficial effects to animals, including but not limited to ...  
WO/2017/197993A1
Provided are a Serratia liquefaciens ZMT-1 the collection No. of which is CCTCC NO:M2016170, and a method for producing Heliotropin by using the Serratia liquefaciens ZMT-1 strain or an enzyme produced by the Serratia liquefaciens ZMT-1 ...  
WO/2017/198890A1
The invention relates to a host cell, preferably a Myceliophthora thermophila cell, which presents a lower expression and/or secretion of non-contributory cellulolytic enzymes, preferably wherein the non-contributory cellulolytic enzyme ...  
WO/2017/197588A1
Provided are a glyphosate-resistant gene screening method, an EPSPS mutant gene having glyphosate resistance screened by the method, an EPSPS and C-P Lyase deficient strain and a use thereof.  
WO/2017/200183A1
The present invention relates to a pharmaceutical composition for preventing or treating hyperphosphatemia and kidney disease and a health functional food for improving hyperphosphatemia and kidney disease by using a Lactobacillus sp. KC...  
WO/2017/200815A1
An aerobic treatment system includes a plurality of highly porous, high surface area, inert, synthetic, inorganic, or natural material particles, having a specific gravity of less than 1.0 that float on an enclosed aqueous environment wh...  
WO/2017/198085A1
A DoxA protein mutant represented by an amino acid sequence such as SEQ ID No.16, and a coding gene thereof. The protein mutant or the coding gene thereof can be used for producing doxorubicin. Streptomyces capable of efficiently express...  
WO/2017/197887A1
An Escherichia coli JLTrp strain and application thereof in L-tryptophan synthesis. The strain has a culture collection number of CGMCC No.7.217 and is resistant against multiple antibiotics. The method using the strain for fermentation-...  
WO/2017/199200A1
The invention relates to a bacterial strain of Rhodococcus biphenylivorans named Palladio 22 and registered at the BCCM-LMG Bacteria Collection under registration number LMG P-29520. The invention also relates to a method for the product...  
WO/2017/200563A1
Entomopathogenic fungal strains, compositions, and methods and compositions of ucing and using the strains for reducing overall insect damage.  
WO/2017/195873A1
The present invention relates to a yeast cell of Yarrowia lipolytica, a cell culture product thereof or an extract of the same. The aforesaid yeast cell, cell culture product and extract of the same are characterized by containing L-hydr...  
WO/2017/196790A1
Eukaryotic algae, which play a fundamental role in global CO2 fixation, enhance the performance of the carbon-fixing enzyme RuBisCO by placing it into an organelle called the pyrenoid where the enzyme's activity is enhanced by the carbon...  
WO/2017/190671A1
Provided is a method for the high expression of a recombinant human serum albumin, characterized in comprising the step of co-expressing: (a) a human serum albumin gene, and (b) one or more rHSA expression promoting factor genes in a yea...  
WO/2017/191884A1
The present invention relates to a novel Alcanivorax sp. A28-3 strain. More particularly, the present invention relates to an Alcanivorax sp. A28-3 strain capable of producing neoagarobiose hydrolase which can saccharify neoagarobiose, a...  
WO/2017/190203A1
The present invention relates to a method for analysing microbial growth and capable of correcting optical density readings and calculating kinetic growth parameters of one or more micro-organism cultures. The data analysis obtained make...  
WO/2017/185738A1
Provided is a genetically engineered biological indicator; an exogenous gene is introduced into an indicating microorganism by means of genetic engineering technology, the exogenous gene comprising a promoter, a reporter gene, and a sele...  
WO/2017/189814A1
The present invention describes methods of identifying high-risk populations or individuals who have positive serology for T.gondii. These methods include obtaining a biological sample from a subject; determining the level of T.gondii cy...  
WO/2017/186146A1
A product and preparation method therefor, the product being obtained by further probiotic fermentation after culturing a macro fungus by using a fruit and vegetable culture medium in which no protein component is added.  
WO/2017/186026A1
Provided is a method for constructing engineered corynebacterium glutamicum bacteria having a high production of L-lysine. The engineered bacteria are constructed by deactivating the NCgl1221 gene of corynebacterium glutamicum, and the n...  
WO/2017/188518A1
The present invention relates to: a Shewanella oneidensis microorganism for synthesizing formic acid; and a method for synthesizing formic acid by using the same. In the present invention, Shewanella oneidensis was first used for synthes...  
WO/2017/185244A1
The present invention discloses an RT-PCR-HRM or PCR-HRM primer, reagent, and method for rapidly distinguishing four types of serum dengue virus.  
WO/2017/181920A1
Provided is a method for preparing recombinant human granulocyte colony-stimulating factor; the cDNA used is obtained on the basis of a human source sequence modifed according to Escherichia coli codon preference, and has a high level of...  
WO/2017/182442A1
The present invention relates to RImA-inactivated filamentous fungal cells secreting a polypeptide of interest and methods of producing a secreted polypeptide of interest in said cells as well as methods of producing said cells.  
WO/2017/183793A1
Streptomyces species strain S-8 isolated from turfgrass rhizosphere soil according to the present invention has been confirmed to have excellent root colonization ability, and to inhibit the growth of Rhizoctonia solani, Pythium graminic...  
WO/2017/183936A1
The present invention provides: a method for correcting a microalgae gene without DNA introduction by using a RNA-guided engineered nuclease (RGEN) RNP complex; and a microalgae variant with a corrected gene. The gene correction method a...  
WO/2017/184884A1
Provided are methods and yeast cultures for producing polyol lipids and polyol lipid compositions.  
WO/2017/178053A1
The present invention relates to a novel strain of Lactobacillus rhamnosus, compositions comprising said strain and to methods for the preparation of such compositions.  
WO/2017/178496A1
A novel Akkermansia species has been isolated from fresh faeces obtained from the reticulated python. The species has been named Akkermansia glycaniphilus. It is capable of growing on mucus as a sole carbon and nitrogen source. The speci...  
WO/2017/178879A1
The present invention relates to novel freeze-resistant baker's yeast (Saccharomyces cerevisiae) strains and uses thereof, for example for the preparation of fresh or frozen dough products, e.g., bread. It provides freeze-resistant baker...  
WO/2017/177773A1
Provided are a class of aerobic phosphorus-removing bacterium capable of synthesizing nanoparticles by microbial self-assembly using waste water, comprising: Shewanella sp. CF8-6, Psychrobacter aquimaris X3-1403 and Erythrobacter citreus...  
WO/2017/181203A1
The disclosure relates to isolated microorganisms-including novel strains of the microorganisms-microbial consortia, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorgani...  
WO/2017/174748A3
Surfactants based on a newly discovered class of compounds include a hydrophobic lipid oligomer covalently linked to a peptide or peptide-like chain and a carbohydrate moiety, and a serine- leucinol dipeptide linked to the lipid oligomer...  
WO/2017/174036A1
A method for producing N-acetyl-D-glucosamine and/or D-glucosamine hydrochloride by means of microbial fermentation. By expressing a vitreoscilla hemoglobin in a microorganism, N-acetyl-D-glucosamine and/or D-glucosamine hydrochloride ar...  
WO/2017/174038A1
A method for producing N-acetyl-D-glucosamine and/or D-glucosamine salt by microbial fermentation: improving the effect of UDP-acetyl-D-glucosamine-2-isomerase in the microbe in order to produce N-acetyl-D-glucosamine and/or D-glucosamin...  
WO/2017/174039A1
The present invention provides a method for producing N-acetyl-D-glucosamine and/or a D-glucosamine salt by means of microbial fermentation. The method produces the N-acetyl-D-glucosamine and/or the D-glucosamine salt by increasing the e...  
WO/2017/174037A1
Provided is a method for producing N-acetyl-D-glucosamine and a D-glucosamine salt by means of microbial fermentation. The method, by increasing the effect of D-glucosamine-6-phosphate deaminase (NagB) in microbes while reducing the effe...  
WO/2017/173689A1
An application using Tolypocladium inflatum to manufacture a shrimp feed and/or formulation for treating or preventing vibriosis. The shrimp feed is a dry, granulated feed or a fermented feed, wherein 0.01-200 g of Tolypocladium inflatum...  
WO/2017/174748A2
Surfactants based on a newly discovered class of compounds include a hydrophobic lipid oligomer covalently linked to a peptide or peptide-like chain and a carbohydrate moiety, and a serine- leucinol dipeptide linked to the lipid oligomer...  
WO/2017/174040A1
Disclosed is a method for producing N-acetyl-D-glucosamine and/or d-glucosamine salt by means of microbial fermentation. The N-acetyl-D-glucosamine and/or d-glucosamine salt are produced with higher efficiency and higher yield, mainly by...  
WO/2017/176872A1
A nutrient-germinant composition to aid in spore germination and a method for increased spore germination efficiency. The composition comprises L-amino acids, D-glucose and/ or D-fructose, a phosphate buffer, an industrial preservative, ...  
WO/2017/173229A1
Compositions and methods are provided for preventing, ameliorating, or treating a disease caused by a species of bacterial genus Vibrio, for example, cholera caused by V. cholerae, the compositions containing two or more strains of lytic...  
WO/2017/168207A1
A pre-treatment process for lignocellulosic biomass is described, used for producing carbohydrates and other subproducts in two steps, at least one nitrogenated additive, particularly carbamide, being used in at least one step, in a hydr...  
WO/2017/172994A1
Provided are modified Gram-negative bacteria having an increased periplasmic volume. Also provided are methods of expressing exogenous genes in the bacteria and targeting protein production to the periplasmic space.  
WO/2017/172577A1
The present disclosure comprises a device and accompanying method for determining the presence or absence of Methicillin-resistant Staphylococcus aureus in a sample. The disclosure includes the following elements: (1) a lateral flow stri...  
WO/2017/161917A1
System and method of cultivating Cordyceps, specifically provided herein is a system of cultivating Cordyceps comprising: a Helpialus moth trapping device (100); a Hepialus moth eggs screening device (200), wherein the device is connecte...  
WO/2017/162090A1
Provided is a recombinant hansenula-based high dosage hepatitis B vaccine, an HBsAg pure product (stock solution) yield of a recombinant hansenula fermentation broth used for producing the hepatitis B vaccine being 300mg/L – 400mg/L.  

Matches 301 - 350 out of 74,010